Attached files

file filename
10-Q - QTRLY REPORT FOR THE QTR ENDED 6-30-2011 - Tonix Pharmaceuticals Holding Corp.g5359.txt
EX-31.2 - CFO SECTION 302 CERTIFICATION - Tonix Pharmaceuticals Holding Corp.ex31-2.txt
EX-31.1 - CEO SECTION 302 CERTIFICATION - Tonix Pharmaceuticals Holding Corp.ex31-1.txt
EXCEL - IDEA: XBRL DOCUMENT - Tonix Pharmaceuticals Holding Corp.Financial_Report.xls
EX-32.2 - CFO SECTION 906 CERTIFICATION - Tonix Pharmaceuticals Holding Corp.ex32-2.txt

                                                                    EXHIBIT 32.1

                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Tamandare Explorations Inc. (the
"Company") on Form 10-Q for the period ending June 30, 2011 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, David
J. Moss, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and
     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
15th day of August, 2011.

/s/ David J. Moss
David J. Moss
Chief Executive Office